Fate Therapeutics Inc
(STU:F6T)
€
2.915
0.144 (5.2%)
Market Cap: 332.29 Mil
Enterprise Value: 147.14 Mil
PE Ratio: 0
PB Ratio: 0.92
GF Score: 66/100 Fate Therapeutics Inc at Bank of America Healthcare Conference Transcript
May 12, 2022 / 04:20PM GMT
Release Date Price:
€20.88
(-3.78%)
Tazeen Ahmad
BofA Securities, Research Division - MD in Equity Research & Research Analyst
Good morning, everybody. Welcome back to the Bank of America Healthcare Conference. I'm Tazeen Ahmad. I'm one of the Senior SMID Biotech analyst at the bank. It is my pleasure to have our next presenting company here with us, Fate Therapeutics.
J. Scott Wolchko
Fate Therapeutics, Inc. - Founder, CEO, President & Director
Thank you.
Tazeen Ahmad
BofA Securities, Research Division - MD in Equity Research & Research Analyst
Sitting next to me is CEO, Scott Wolchko. Scott, good morning. Thank you for coming (inaudible)
J. Scott Wolchko
Fate Therapeutics, Inc. - Founder, CEO, President & Director
Good morning. Thanks for having us. Nice to see you in person.
Tazeen Ahmad
BofA Securities, Research Division - MD in Equity Research & Research Analyst
Yes, for sure. So maybe you could start off by giving everybody a
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot